The Pilot and Feasibility Program is directed by Atul Bhan. In this role, Dr. Bhan will evaluate letters of intent for suitability, assist the Center director with identification of appropriate reviewers, and examine reviews received. Dr. Bhan is charged specifically with reviewing these initial funding proposals in the context of the overall programmatic goals of the Center in fostering new digestive disease investigators and advancing understanding of IBD. He will also chair the meeting of the CSIBD Executive Steering Committee that ranks the proposals for funding.
The specific aims of the Pilot and Feasibility Program are to (1) recruit new investigators into IBD research by providing funding for IBD related nascent research programs, and (2) generate new ideas related to IBD research by providing funding for innovative high risk high payoff lines of investigation. As detailed in the Research Strategy of this program, achievement of these goals is evident in the success that P/F recipients have had in bringing pilot projects to the juncture at which they have led to ongoing research funding by external peer-reviewed agencies as well as results warranting publication in peer-reviewed journals. In the last ten years of funding (2005-2014), 35 Pilot and Feasibility Program award recipients have gone on to become independent investigators; 10 of these transitions to independence occurred since the last competing renewal in 2009.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK043351-29
Application #
9625637
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2019-01-01
Budget End
2019-12-31
Support Year
29
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Graham, Daniel B; Jasso, Guadalupe J; Mok, Amanda et al. (2018) Nitric Oxide Engages an Anti-inflammatory Feedback Loop Mediated by Peroxiredoxin 5 in Phagocytes. Cell Rep 24:838-850
Vedamurthy, Amar; Xu, Louise; Luther, Jay et al. (2018) Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis. Dig Dis Sci 63:2740-2746
Wein, Marc N; Foretz, Marc; Fisher, David E et al. (2018) Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential. Trends Endocrinol Metab 29:723-735
Simon, Tracey G; Van Der Sloot, Kimberley W J; Chin, Samantha B et al. (2018) IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn's Disease. Inflamm Bowel Dis 24:2247-2257
Schirmer, Melanie; Denson, Lee; Vlamakis, Hera et al. (2018) Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course. Cell Host Microbe 24:600-610.e4
Zhang, Wei; Jiao, Lefei; Liu, Ruixin et al. (2018) The effect of exposure to high altitude and low oxygen on intestinal microbial communities in mice. PLoS One 13:e0203701
Akcakaya, Pinar; Bobbin, Maggie L; Guo, Jimmy A et al. (2018) In vivo CRISPR editing with no detectable genome-wide off-target mutations. Nature 561:416-419
Kim, Byeong-Moo; Abdelfattah, Ahmed Maher; Vasan, Robin et al. (2018) Hepatic stellate cells secrete Ccl5 to induce hepatocyte steatosis. Sci Rep 8:7499
Yassour, Moran; Jason, Eeva; Hogstrom, Larson J et al. (2018) Strain-Level Analysis of Mother-to-Child Bacterial Transmission during the First Few Months of Life. Cell Host Microbe 24:146-154.e4
Perugino, Cory A; AlSalem, Sultan B; Mattoo, Hamid et al. (2018) Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. J Allergy Clin Immunol :

Showing the most recent 10 out of 1166 publications